Hepatitis C News and Research

Latest Hepatitis C News and Research

Georgia reminds adults to get vaccinated

Georgia reminds adults to get vaccinated

16 Sep 2011
Teva to invest in CDI for development of novel antiviral drugs

Teva to invest in CDI for development of novel antiviral drugs

16 Sep 2011
Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

16 Sep 2011
Experimental malaria vaccine shows positive results among children in small Burkina Faso study

Experimental malaria vaccine shows positive results among children in small Burkina Faso study

16 Sep 2011
VBI Vaccines completes acquisition of Epixis

VBI Vaccines completes acquisition of Epixis

15 Sep 2011
Patients with hepatitis C may benefit from 24 week telaprevir-based regimen

Patients with hepatitis C may benefit from 24 week telaprevir-based regimen

15 Sep 2011
NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

15 Sep 2011
'Achilles' heels' within HCV virus

'Achilles' heels' within HCV virus

14 Sep 2011
Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

14 Sep 2011
Breakthrough opens new avenues for hep C vaccine

Breakthrough opens new avenues for hep C vaccine

12 Sep 2011
Specialists propose changes to allocation and distribution of organs for liver transplants

Specialists propose changes to allocation and distribution of organs for liver transplants

12 Sep 2011
Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

12 Sep 2011
HPV vaccination updates

HPV vaccination updates

9 Sep 2011
Vertex VX-509 12-week Phase 2a study on RA meets two primary endpoints

Vertex VX-509 12-week Phase 2a study on RA meets two primary endpoints

6 Sep 2011
NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

6 Sep 2011
Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

6 Sep 2011
Gilead to amend design of ongoing clinical trials against chronic hepatitis C

Gilead to amend design of ongoing clinical trials against chronic hepatitis C

5 Sep 2011
Wis. patients getting tested for HIV after misuse of equipment

Wis. patients getting tested for HIV after misuse of equipment

2 Sep 2011
Engineered virus shows promise in cancer therapy via bloodstream

Engineered virus shows promise in cancer therapy via bloodstream

2 Sep 2011
Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection

Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection

31 Aug 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback